Company: ARTL
Filing Date: 2025-06-13
Form Type: 8-K
Source: 0001640334-25-001046
Chunk: 1

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-06-13
Form: 8-K
Item: Item 3.03
Chunk 1
---
one) for six (6) Reverse Split ratio will automatically be entitled to receive one whole share of Common Stock for each such fractional share. All of the Company’s current outstanding warrants to purchase shares of Common Stock and other derivatives automatically adjust per their terms to reflect the Reverse Split.

What happens to the warrants from the October 2020 financing (maturity date October 13, 2025)?

These warrants to purchase Artelo’s Common Stock were originally issued at an exercise price of $0.75 per share and expire on October 13, 2025. With the 1 (one) for six (6) reverse split, 6 of these warrants are now exercisable at $4.50 ($0.75 x 6) for one post-split share of Artelo’s Common Stock. Thus, for example, 6,000 of these warrants would be exercisable to purchase 1,000 post-reverse-split shares of Common Stock (6,000/6) at $4.50 each.

The Certificate of Change is filed as Exhibit 3.1 hereto and are incorporated herein by reference.

Item 8.01. Other Events.